ArticleJournal of immunotherapy and precision oncology2021

Targeting CD47/SIRPα in Acute Myeloid Leukemia and Myelodysplastic Syndrome: Preclinical and Clinical Developments of Magrolimab.

Fadi Haddad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.